INTRODUCTION

Background. Smoking reduces HDL-C and its sub-
Cigarette smoking is a major risk factor in coronary fractions, and smoking cessation leads to normalizaheart disease. There may be many mechanisms of ef- nonsmokers [1] [2] [3] [4] [5] . In addition, environmental tobacco Methods. Ten male and 17 female smokers refrained smoke has been shown to have a negative impact on from smoking for 77 days. The patch was utilized durblood lipoproteins [6] . demonstrated with smoking cessation [3, 7] . This raises were controls.
the question: What factors associated with cigarette
Results. HDL-C, HDL 2 -C, and HDL 3 -C levels were sigsmoke specifically impact blood lipids? Nicotine has nificantly lower in smokers when compared with conbeen studied as a possible cause of atherogenic altertrols. These differences were sustained during the iniations in lipoprotein profiles. Quensel et al. [8] found tial 35 days when using the patch. Over the following 42 that chewing nicotine gum for 2 weeks by young healthy days, however, these lipoproteins normalized to values volunteers had no effect on blood lipids. The impact on similar to those of control subjects. Females who quit results of using nonsmoking volunteers, rather than smoking gained 2.1 kg after the patch was removed.
smokers seeking to quit, and limiting treatment to 2
Conclusions. It was concluded that nicotine as adweeks is unknown. Allen et al. [9] found that HDLministered by the transdermal nicotine patch inhibits C increased following smoking cessation even though normalization of HDL-C, HDL 2 -C, and HDL 3 -C in those subjects were treated with a transdermal nicotine patch who have quit smoking. Removal of the patch results in doses of 21, 14, or 7 mg/day. HDL-C increased signifiin normalization of these lipoproteins. The patch ap-cantly in patients exposed to 21 and 14 mg/day, but not peared to prevent weight gain among female sub-in patients exposed to 7 mg/day. It is a surprising find-
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ing that the lowest dose of nicotine prevented normalKey Words: lipoproteins; smoking; nicotine; cessa-ization of HDL-C, while the higher doses and the plation.
cebo did not. The present study was undertaken to determine the effects of a transdermal nicotine patch ("patch") on HDL-C and its subfractions in the early stages of smoking cessation among those with a sub-contributes to coronary heart disease, and circum-were placed in the local community requesting nonstances which sustain the depression represent a clini-smoking volunteers to participate. In response, 9 female cally significant finding. and 7 male lifetime nonsmokers volunteered to serve as controls (nonsmokers). Participants were healthy as
METHODS
determined by a medical history questionnaire. No statistically significant differences existed between exThe present study of the influence of transdermal smokers and nonsmokers with respect to age, height, nicotine on HDL-C was a secondary project within a or body weight (see Table 1 ). Ex-smokers used cigalarger investigation of the efficacy of participation by rettes only and no other tobacco (pipe, cigar, or smokea significant partner during a smoking cessation trial. less tobacco) or nicotine (chewing gum) products. All Volunteers to participate in the smoking cessation proprocedures were approved by the University Human gram were recruited by newspaper advertisements, flySubjects Board and all subjects signed an informed coners, and public service announcements. Responses were sent statement before entering the study. received from 151 individuals of which 104 individuals Subjects reported to the laboratory in a 12-h postwere eligible smokers for the cessation program. The prandial state on three occasions (days 0, 35, and 77). remaining 47 respondents were unable to commit to Ex-smokers abstained from cigarette smoking from day the requirements of the program. From this pool, 96 1 through day 77. From day 1 through day 35, Exindividuals were randomly assigned to treatment and smokers used a transdermal nicotine patch (22 mg/day). control groups. Three treatment groups containing 72
The research of Gorsline et al. [10] indicates that the individuals received a transdermal nicotine patch as a patch dose utilized equates to a steady-state plasma portion, or all, of their smoking cessation treatment.
nicotine concentration of approximately 17 mg/ml. One group (n ϭ 24) was provided the nicotine patch as From day 36 through day 77, the patch was not used their only aid in smoking cessation while two groups by ex-smokers. received group counseling either with (n ϭ 24) or withIn order to replicate as close to normal conditions out (n ϭ 24) spouses participating. The remaining 24 associated with smoking cessation as possible, exsubjects were assigned to a non-counseling, non-patch smokers were encouraged to act as naturally as possicontrol group for the larger investigation. From the 72 ble, despite their commitment to the study. This means participants who received the patch, volunteers were if subjects felt compelled to consume more food upon recruited to enter the present study. Following a full cessation (a likely occurrence), they should feel free to description of study procedures, 68% of the 72 potential do so, because weight gain is a typical outcome of smokparticipants (25 male, 24 female) smokers (ex-smokers) ing cessation [3] . Increased caloric intake and the loss volunteered to participate in the present study of HDLof acute metabolic stimulation associated with inhaling C. All of the 72 potential participants were encouraged cigarette smoke are major contributors to cessationto be involved in the present study; however, some were related weight gain [3, 11] . The only stipulation regardunwilling to have blood drawn over the course of the ing diet was to make no qualitative changes. Our previlarger study. For various reasons including skin irritaous research has demonstrated that subjects typically tion, scheduling conflicts, inability to stop smoking, and will eat more, but will eat more of the kinds of food to suspected pregnancy, 15 male and 7 female ex-smokers which they are accustomed, thus maintaining the same failed to complete the present study. The ex-smokers percentage of fat, carbohydrate, protein, and alcohol in group, therefore, resulted in 17 females and 10 males at the diet [3] . With the exception of smoking cessation, the completion of the study who successfully abstained from smoking for 77 days (see Table 1 ). Advertisements subjects were instructed to refrain from making specific analysis of variance (gender ϫ group ϫ day) was employed to determine statistically significant differences.
Note. Mean Ϯ standard deviation. * Significantly greater than males of the same group (P Յ 0.05).
A Scheffé post hoc test was performed to determine ** Significantly greater than day 0 and day 35 (P Յ 0.05).
single degree of freedom differences. The criterion of statistical significance was set at the P Յ 0.05 level. 3.46 Ϯ 0.41, day 35 ϭ 3.43 Ϯ 0.39) prior to, and during
RESULTS
use of, the patch; however, removal of the patch lead to a lower TC/HDL-C ratio at day 77 (ex-smokers ϭ As was expected, precessation levels (day 0) for HDL-3.74 Ϯ 0.84 vs nonsmokers ϭ 3.46 Ϯ 0.39). C, HDL 2 -C, and HDL 3 -C for all ex-smokers and nonsmokers were significantly (P Ͻ 0.05) higher in females DISCUSSION when compared with males (see Table 2 ). Precessation levels (day 0) for HDL-C, HDL 2 -C, and HDL 3 -C for exThe present data demonstrate that nicotine as administered by a transdermal nicotine patch inhibits smokers, males and females combined, were significantly (P Ͻ 0.05) below those of nonsmokers (see Fig. normalization of HDL-C, HDL 2 -C, and HDL 3 -C in those who quit smoking. Following removal of the patch, 1). HDL-C was lower by 24%, HDL 2 -C was lower by 47%, and HDL 3 -C was lower by 15%. After 35 days of these lipoproteins normalized from day 35 to day 77.
While this investigation is somewhat limited based on wearing the patch, HDL-C, HDL 2 -C, and HDL 3 -C blood levels for ex-smokers had not changed. When the patch the small sample size, these results agree with many other reports which have demonstrated a positive effect had been removed for the preceding 42 days, ex-smokers at day 77 demonstrated significantly increased on HDL-C with smoking cessation [3, 4, 7, 15] .
Removal of the patch for 42 days resulted in similar (P Ͻ 0.05) levels of HDL-C, HDL 2 -C, and HDL 3 -C. HDL-C increased by 21% (males ϭ 18%; females ϭ 26%), improvements of HDL-C and HDL 2 -C that have been documented following smoking cessation for as little as HDL 2 -C by 44% (males ϭ 52%; females ϭ 48%), and HDL 3 -C by 10% (males ϭ 5%; females ϭ 13%) among 10 and 30 days [4, 15] . In the present study, by day 77 of smoking cessation and 42 days after the removal of ex-smokers (see Fig. 1 and Table 2 ); however, HDL 3 -C did not increase significantly in males.
the patch, HDL-C and HDL 2 -C were elevated in males and females alike. In Moffatt et al. [15] , this response Male ex-smokers did not gain weight throughout the study (see Table 3 .). Female ex-smokers, on the other differed from the males, but not the females, where HDL-C and its subfractions were not influenced by 30 hand, gained a significant (P Ͻ 0.05) 2.1 kg at day 77. Male and female nonsmokers did not gain weight. Total days of smoking cessation without the use of the patch.
The improvement in HDL-C following removal of the cholesterol did not change during the study period in any groups. TC/HDL-C ratios were found to be different patch in males was primarily due to the increased HDL 2 -C; however, in females increased HDL 2 -C and (P Ͻ 0.05) between ex-smokers (day 0 ϭ 4.60 Ϯ 0.86, day 35 ϭ 4.67 Ϯ 0.81) and nonsmokers (day 0 ϭ HDL 3 -C were responsible for the increased HDL-C. The it is, then the preponderance of evidence prior to the present study was that nicotine does not affect lipoprotein concentrations. The present data challenge these previous findings. Additional research is required to resolve inconsistencies in the cumulative available data in order to determine whether nicotine is responsible for reductions in healthful lipoproteins among smokers.
The nicotine transdermal patch is in wide use as a nicotine replacement mode which helps cigarette smokers quit smoking. If the patch, and therefore nicotine, prevents normalization of lipoproteins as the present data suggest, the effect is acute and lasts only as long as the patch is in place. The health tradeoffs involved (quitting smoking versus a delay in normalization of lipoproteins) would in the long run seem worthwhile. This is especially true when considering that female exsmokers gained weight when the patch was removed. Thus, although the patch may have prevented normalization of lipoproteins, it also prevented weight gain in females. The latter is a positive outcome, particularly when considering that unwanted weight gain is often cited as the reason for returning to smoking. The present data indicating that weight gain does not occur while the patch is in use are in conflict with other published data that suggest weight gain ranging from 1.6 to 4.0 kg occurs while ex-smokers are using the patch [18] [19] [20] . Long-term follow-ups (12-62 months) of those who have successfully abstained from smoking with the aid of nicotine patches indicate that weight gain does occur [21, 22] . tine patch inhibits the normalization of HDL-C and its subfractions, however; it also limits weight gain. After the removal of the nicotine patch with continued smokcombination of the present data and those of Moffatt ing cessation, the typical normalization of HDL-C folet al. [15] suggest that males and females may have lowing smoking cessation is noted; however, with the differing lipoprotein-cholesterol responses following smoking cessation and removal of the patch.
It is difficult to determine why the present results contrast with those of Allen et al. [9] who found that A different approach was taken by Quensel et al. [8] in smoking and who use the patch is open to question. If
